It appears to be an association between hypothyroidism and hypertension. However, the relation between thyroid function and blood pressure within the normal serum thyrotropin (TSH) range is uncertain. In the fifth Tromsø study, which is a population-based health survey, serum TSH and blood pressure were measured. This gave us the opportunity to test the hypothesis of a relation between serum TSH and blood pressure within the normal serum TSH range. In all 5872 subjects (2623 male subjects) not using blood pressure or thyroxine medication were included in the present study. Within the normal serum TSH range (0.20-4.00 mIU/l), there was a significant and positive relation between serum TSH and both systolic and diastolic blood pressure. Within this range, and adjusted for age, body mass index and smoking status, the systolic blood pressure was 1.4 mm Hg and the diastolic 1.6 mm Hg higher in male subjects in the highest versus those in the lowest serum TSH quartile. The corresponding differences in the female subjects were 4.0 and 2.7 mm Hg, respectively. When dividing this cohort in those with systolic (4160 mm Hg) and diastolic (495 mm Hg) hypertension, serum TSH was higher in the hypertensive subjects, but the differences were only statistically significant for diastolic hypertension (serum TSH 1.8870.82 versus 1.6970.74 mIU/l for male subjects, and 1.7970.78 versus 1.6370.75 mIU/l for female subjects, Po0.05). In conclusion, there is a modest, but significant positive association between serum TSH and blood pressure within the normal serum TSH range.
Introduction
It appears to be a general consensus that hypothyroidism may be associated with hypertension, and conversely, that hypertension is associated with hypothyroidism. [1] [2] [3] The cause of this is uncertain, but may be related to increased systemic vascular resistance, 3 which is the case in subjects with subclinical hypothyroidism. 4 Furthermore, it appears to be a negative relation between free thyroxine (free T 4 ) and blood pressure salt sensitivity even in euthyroid subjects. 5 Accordingly, it would be of interest to examine the relation between blood pressure and thyroid function even in euthyroid subjects. This could be of potential importance in the discussion on whether to treat subjects with subclinical hypothyroidism, 6, 7 as well as when discussing what should be considered the upper 'normal' thyrotropin (TSH) level.
We recently had the opportunity to examine the relation between serum TSH and blood pressure as both were measured in the fifth Tromsø study, a population-based health survey that included more than 8000 subjects. 8 
Patients and methods
The fifth Tromsø study was performed as a general health survey in 2001 in a manner similar to the previous ones. 9 All men and women older than 29 years, living in the municipality of Tromsø and that participated in the second phase of the fourth Tromsø study 10 or became 30, 40, 45, 60 or 75 years old during 2001, were invited to participate. All subjects filled in a health questionnaire including smoking status, use of thyroxine and blood pressure lowering medication.
Those who smoked daily were classified as smokers, the others as non-smokers. Height, weight and blood pressure were measured as described previously. 10 Body mass index (BMI) was calculated as weight (kg) divided by squared height (m 2 ). Non-fasting blood samples were drawn between 0800 and 1600 h, and analyzed for serum TSH as described previously (reference range 0.20-4.00 mIU/l). 11 The time between blood sampling and blood pressure measurement was 5 and 15 min.
Statistical analyses
Normal distribution was evaluated with determination of skewness and kurtosis and all dependent variables were considered normally distributed. The subjects were divided in six serum TSH groups: below the reference range (o0.20 mIU/l); quartiles within the TSH reference range (0.20-1.1 mIU/l, 1.12-1.53 mIU/l, 1.54-2.09 mIU/l and 2.10-4.00 mIU/l); and above the reference range (44.00 mIU/l). To test for interactions regarding blood pressure, a factor analysis with TSH group, gender and smoking status (current smoker/nonsmoker) as factors, and age and BMI as covariates, was performed. This revealed a significant interaction between gender and TSH group, and male subjects and female subjects were therefore analyzed separately.
The relation between blood pressure and serum TSH was not linear, except within the reference range. To test for linear trends within the reference range a multiple linear regression model was used with the variable in question as dependent variable, and smoking status, age, BMI and TSH quartile (within the reference range) as covariates. This model was also used to evaluate serum TSH as a continuous variable in relation to blood pressure.
Subjects with serum TSH level outside the reference range were compared with those within this range with linear regression using covariates as above, as was comparisons between normotensive and hypertensive subjects. Systolic hypertension was defined as systolic blood pressure 4160 mm Hg, and diastolic blood pressure as diastolic blood pressure 495 mm Hg.
For statistical purposes serum TSH o0.05 mIU/l was considered as 0.025 mIU/l in the analyses.
Unless otherwise stated, all data are expressed as mean7s.d. All tests were carried out two-sided, and Po0.05 was considered statistically significant. Statistical analyses were performed with SPSS version 11.0 (SPSS Inc., Chicago, IL, USA).
Ethics
The Regional Ethics Committee approved the study, and all participants gave their written informed consent.
Results
A total of 10 419 men and women, aged 29-89, were invited to the fifth Tromsø study and 8128 persons attended. Serum TSH was successfully measured in 7954. Information on blood pressure medication was available in 7794 subjects and 6239 of these did not use blood pressure medication. Three hundred and sixty-seven of these subjects were using thyroxine medication, and the remaining 5872 included in the study. Their characteristics are shown in Table 1 . According to the health questionnaire, 2.1% had diabetes, 3.2% had previous coronary infarction, 4 .1% angina pectoris and 1.9% had suffered a stroke.
When the subjects were grouped according to TSH levels (o0.20 mIU/l, quartiles within the reference range 0.20-4.00 mIU/l and 44.00 mIU/l) there was no linear relation between serum TSH level and blood pressure. Thus, those with serum TSH above as well as those with serum TSH below the reference range, had higher systolic and diastolic blood pressures than those within the reference range (Tables 2 and 3 ). However, these differences did not reach statistical significance. Within the serum TSH reference range there was in both genders a significant linear rise in diastolic blood pressure with increasing TSH quartile, and in female subjects also for systolic blood pressure (Tables 2 and 3) . After adjusting for age, BMI and smoking status, the difference between the highest and lowest serum TSH quartile was for systolic blood pressure 1.4 and (Tables 2  and 3 ). There was within the serum TSH reference range in both genders a significant increase in BMI and age with increasing serum TSH quartile (Tables  2 and 3 ).
Blood pressure and TSH
In the multiple linear regression model with serum TSH as a continuous variable within the serum TSH reference range, serum TSH was a significant predictors for diastolic blood pressure in both genders and also for systolic blood pressure in the female subjects (Table 4) .
In both genders, those with systolic or diastolic hypertension had higher serum TSH levels than those without hypertension, but the difference was only significant for diastolic hypertension (Table 5) .
Discussion
In the present study, we have found a positive association between serum TSH and systolic and diastolic blood pressure within the serum TSH reference range 0.20-4.00 mIU/l.
As expected, there was with increasing serum TSH also a rise in age and BMI, two factors that are well known to be positively associated with blood pressure. However, the relation between serum TSH and blood pressure also persisted after adjusting for these factors as well as smoking status in a multiple regression model. Thus, the difference in adjusted systolic and diastolic blood pressure between those in the lowest and highest quartile within the serum TSH reference range was approximately 2-3 mm Hg, a difference that could be of potential clinical importance. In addition, there is a recent report from Denmark by Knudsen et al. 12 showing that there is a positive relation between thyroid function and BMI within the normal TSH range. As both blood pressure 13 and overweight 14 are risk factors for cardiovascular disease one could hypothesize a relation between serum TSH within the normal range and future morbidity and mortality, similar to that suggested for plasma glucose within the normal range. 15 So far an association between subclinical hypothyroidism and cardiovascular disease 16 as well as all-cause mortality 17 has been reported, but whether this also applies to those in the upper normal TSH range remains to be demonstrated. Several large epidemiological studies including TSH measurements have been published in recent years from the US, 18 Denmark 12 and Norway, 19 and the question will probably be answered within the near future.
There are reports on higher prevalence of hypothyroidism in subjects with hypertension. Thus, in a study by Streeten et al. 20 on 688 hypertensive subjects the prevalence of hypothyroidism was 3.6%. Similarly, Gumieniak et al. 5 found significantly higher serum TSH levels and significantly Blood pressure and TSH A Iqbal et al lower free T 4 index in 194 hypertensive subjects as compared with 90 normotensive subjects. When we divided our subjects according to systolic or diastolic hypertension we could only partially confirm these findings regarding subjects with serum TSH within the normal range. Although the serum TSH levels were higher in those with hypertension, the difference was only significant regarding diastolic hypertension. This was rather surprising as we found a clear association between blood pressure and serum TSH within the normal range. However, this probably reflects the reduction in statistical power compared to the analysis where the cohort was divided in quartiles and also compared to the regression analysis where serum TSH was treated as a continuous variable. It could not be explained by our exclusion of subjects outside the serum TSH reference range, as inclusion of those above and/or below that range did not notably affect the results. The cause of the positive relation between serum TSH and blood pressure is uncertain but several mechanisms have been suggested. Thus, it appears to be an increased systemic vascular resistance in subjects with hypothyroidism, 4 and also a positive association between serum-free T 4 index and blood pressure salt sensitivity. Furthermore, it could be related to catecholamine levels which have been reported to be higher in hypothyroid than in euthyroid subjects, and also to increased total body water and sodium. 2 The association between serum TSH and blood pressure found in our study is no proof of causality. To prove a causal relationship one would have to demonstrate a blood pressure fall after thyroxine treatment. This has been shown in some studies on patients with overt hypothyroidism [20] [21] [22] , but not in a study on subjects with subclinical hypothyroidism. 23 However, to demonstrate a 2 mm Hg effect on systolic blood pressure in subjects with serum TSH within the normal range one would have to include almost 3000 subjects to have an 80% chance of a statistically significant result. At present, such a study appears unlikely to be started.
The thyroid function is closely related to iodine status, and epidemiological studies have linked increases in dietary iodine with an increased incidence of autoimmune thyroid disease. 24 Iodine consumption all over Norway is generally high owing to high iodine content of dairy products and intake of salt water fish. 25 In costal Northern Norway, to which the Tromsø area belongs, the iodine intake was determined in 1971-72 and found to be sufficient. 26 We have previously published the prevalence of thyroid antibodies determined in the Tromsø studies from 1979-80 and 1986-87, and have found antibodies to thyroid microsomal antigen to be present in 6.1% of the population, which is comparable to that found in other areas. 27 Although there have been no studies on the prevalence of thyroid diseases in our area, we find it likely that our population in this respect is similar to that in most of Western Europe.
Our study has some weaknesses. In particular, we only measured serum TSH, whereas measurements of free T 4 and free T 3 could have given additional information. Furthermore, the number of subjects with elevated serum TSH levels was rather low, and our results therefore mainly apply to those with serum TSH within the reference range. On the other hand, the large number of subjects studied with serum TSH in this range, and the careful adjustment for the main confounding factors age, BMI and smoking status, gives our results considerable strength.
In conclusion, there is a positive association between blood pressure and serum TSH within the normal TSH range, but whether this association is causal or not, and also its clinical importance, remain to be clarified. 
